At the End of the Day on the Stock Exchange: META, AMZN, THYAO and More

Market Agenda: Important Developments

End-of-day reports are crucial for investors to keep a pulse on the market. Today, significant developments in the technology and energy sectors, as well as noteworthy data for Turkish Airlines and domestic companies, have emerged.

Meta’s New Energy Investments

Meta (META) announced plans to acquire a total of 2.6 gigawatts of energy from Vistra's nuclear facilities as part of its growth strategy in the energy sector. Additionally, agreements will be made with Oklo to establish a modern nuclear technology campus with a capacity of 1.2 gigawatts in southern Ohio.

Amazon’s Innovative Drug Presentation

Amazon (AMZN) has begun offering a new pill form of Novo Nordisk’s (NVO) weight loss drug Wegovy on its pharmacy platform. This move brings a new dimension to Amazon’s initiatives in the healthcare sector.

Merck’s Major Acquisition Plan

Merck (MRK) is in talks to acquire Revolution Medicines (RVMD), which focuses on cancer treatments, with a valuation between 28 and 32 billion dollars. This acquisition could further strengthen Merck's portfolio.

Turkish Airlines and Domestic Companies

Turkish Airlines (THYAO) reported that the total number of passengers in December 2025 is expected to reach 7.30 million, reflecting a 13.5% increase compared to the previous year. This rise indicates a resurgence in global travel demand.

Tuğçelik (TUCLK), through its agreement with BSH Home Appliances Industry, aims to achieve an additional revenue of 13 million euros during the years 2026-2028. This is an important development in terms of Tuğçelik's growth strategies.

Turkey Insurance’s Strong Growth Figures

Turkey Insurance (TURSG) announced that its gross premium production for the period of January-December 2025, which has not yet undergone independent auditing, reached 147.11 billion TL, showing a 45% increase compared to the previous year. This strong growth is considered an indication of improvement in the sector.

All these developments present important strategies and opportunities for investors. However, the information provided here should not be regarded as definitive investment advice.